Form D · Biotechnology
Pictor Labs, Inc.
Los Angeles, CA · CIK 0001796802
Offering snapshot reported Aug 21, 2024 · SEC filing
- Reported sold
- $20.6M Offering amount: $30M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 6, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2024 | Initial | $20,586,916 | No comparison | 8 | SEC filing |
| May 27, 2022 | Initial | $7,607,500 | No comparison | 5 | SEC filing |
| May 27, 2022 | Amendment | $3,625,691 | $3,008,818vs Oct 7, 2020 | 9 | SEC filing |
| Oct 7, 2020 | Initial | $616,873 | No comparison | 2 | SEC filing |
| Aug 10, 2020 | Initial | $9 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-522135
Offer and Sale of Series B Preferred Stock (and the Common Stock issuable thereunder); and Offer and Sale of Warrants to Purchase Series B Preferred Stock (and the Common Stock issuable thereunder)
Source: Form D, filed Aug 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bauke Anninga | Director |
| Scott Barclay | Director |
| Robert Crutchfield | Director |
| Gilbert Hakim | Director |
| Frank Hsin | Director |
| Aydogan Ozcan | Director, Promoter |
| Melih Poyraz | Director |
| Yair Rivenson | Director, Executive, Promoter |
| Polat Sen | Director |
| Christopher Wilson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11390 W Olympic Blvd., Suite 250
Los Angeles, CA, 90064
Los Angeles, CA, 90064